2015, Number 2
Clinical-epidemiological profile of patients with chronic obstructive pulmonary disease in 'Jardinillos' Health Center
Language: Spanish
References: 25
Page: 108-118
PDF size: 536.66 Kb.
ABSTRACT
Background: chronic obstructive pulmonary disease is mainly characterized by a chronic limitation to little-reversible air flow. Knowing this disease facilitates giving the patients a better quality of life.Objective: to study the clinical-epidemiological profile of patients in Jardinillos Health Center, in Palencia area, to give them a better quality of life.
Method: a cross-sectional, descriptive, observational study was conducted in 228 patients with the diagnosis of chronic obstructive pulmonary disease from January to December, 2013. A previously structured and codified form for collecting data was used to know the clinical-epidemiological profile. The clinical and epidemiological histories of each patient were revised. Data were analyzed by means of Excel program and the confirmed patients were included.
Results: male patients between 71 and 80 years old predominated. The most seen comorbidity was hypertension and diabetes mellitus; a 61, 8 % of the patients were smokers. Regarding vaccination, a 65, 8 % of the patients were vaccinated against influenza and pneumococcus. The 86 % of the studied patients were negative to alcoholism. The 85, 96 % of the patients presented exacerbation of chronic obstructive disease and required a change in the treatment or admission in the hospital. Most of the patients belonged to the acuter phenotype with chronic bronchitis. The treatment with long-acting bronchodilators was the most used one.
Conclusions: most of the patients were male and of advanced years. The most frequent comorbidity was hypertension and diabetes mellitus and a 61, 8 % of the patients were smokers. The acuter phenotype with chronic bronchitis was the most identified. The treatment with long-acting bronchodilators was the most used one.
REFERENCES
Guía de Práctica Clínica para el Diagnóstico y Tratamiento de Pacientes con Enfermedad Pulmo-nar Obstructiva Crónica (EPOC) - Guía Española de la EPOC (GesEPOC). Arch Bronconeumol [Internet]. Jun 2012 [citado 30 May 2014];48(Supl 1):1-83[aprox. 2 p.]. Disponible en: http://apps.elsevier.es/watermark/ctl_servlet?_f=10&pident_articulo=90141716&pident_usuario=0&pcontactid=&pident_revista=6&ty=92&accion=L&origen=bronco&web=www.archbronconeumol.org&lan=es&fichero=6v48nSupl.1a90141716pdf001.pdf
Miravitlles M, Soler-Cataluña JJ, Calle M, Molina J, Almagro P, Quintano JA, et al. Guía española de la EPOC (GesEPOC). Tratamiento farmacológico de la EPOC estable. Arch Bronconeumol [Internet]. Jul 2012 [citado 30 May 2014];48(7):247-57:[aprox. 6 p.]. Disponible en: http://www.archbronconeumol.org/es/guia-espanola-epoc-gesepoc-tratamiento/articulo/90141601/ 3. Atkinson W, Hamborsky J, Wolfe S, eds. Epide-miology & Prevention of Vaccine-Preventable Dis-eases. 10th ed. Washington DC: Public Health Foundation; 2008.
Sociedad Española de Medicina de Familia (semFYC), Sociedad Española de Neumología y Ci-rugía Torácica (SEPAR). Grupo de trabajo de la guía de práctica clínica sobre atención integral al paciente con enfermedad pulmonar obstructiva crónica (EPOC) [Internet]. Barcelona: semFYC; 2010 [citado 30 May 2014]. Disponible en: http://www.guiasalud.es/GPC/GPC_468_EPOC_AP_AE.pdf
Jithoo A, Enright PL, Burney P, Buist AS, Bate-man ED, Tan WC, et al. BOLD Collaborative Re-search Group. Case-finding options for COPD: re-sults from the Burden of Obstructive Lung Disease study. Eur Respir J. 2013 Mar;41(3):12-6. 7. Steenbruggen I, Zielinski J, Lange P, Price D, Soriano JB. A BOLD statement on how to case-find moderate/severe COPD. Eur Respir J. 2013 Mar;41(3):42-5.
Jiménez Ruiz CA, Riesco Miranda JA, Altet Gó-mez N, Lorza Blasco JJ, Signes-Costa Miñana J, Solano Reina S, et al. Tratamiento del tabaquismo en fumadores con enfermedad pulmonar obstructi-va crónica. Arch Bronconeumol [Internet]. 2013 [citado 30 May 2014];49(8):[aprox. 6 p.]. Disponi-ble en: http://www.archbronconeumol.org/es/tratamiento-del-tabaquismo-fumadores-con/articulo/90218193/
Regidor E, Gutierrez-Fisac JL, Alfaro M. Patron de mortalidad en Espana, 2008 [Internet]. Ma-drid: Ministerio de Sanidad, Politica Social e Igual-dad; 2011 [citado 30 May 2014]. Disponible en: http://www.msc.es/ca/estadEstudios/estadisticas/estadisticas/estMinisteriO Mortalidad/docs/Patrones_de_Mortalidad_en_Espana_2008.pdf
18.Vestbo J, Hurd SS, Agusti AG, Jones PW, Vo-gelmeier C, Anzueto A, et al. Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease, GOLD Executive Summary. Am J Respir Crit Care Med. 2013 Feb 15;187(4):347-65. 19. Guyatt GH, Oxman AD, Kunz R, Woodcock J, Brozek J, Helfand M, et al. GRADE guidelines: 8. Rating the quality of evidenced indirectness. J Clin Epidemiol. 2011 Dec;64(12):1303-10.